You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkins lymphoma

Showing 1 - 25 of 5,128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

Hodgkin Lymphoma, Adolescent Behavior, Chemo Effect Trial (Description of therapeutical results)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Description of therapeutical results
  • (no location specified)
Dec 15, 2022

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
Has Results
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

CD20 Positive Non Hodgkin Lymphoma Trial in United States (CPO107)

Recruiting
  • CD20 Positive Non Hodgkin Lymphoma
  • Los Angeles, California
  • +4 more
Aug 9, 2022

Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,

Recruiting
  • Childhood Non-Hodgkin Lymphoma
  • +2 more
  • Goal Management Training (GMT)
  • Brain Health Workshop (BHW)
  • Oslo, Norway
  • +2 more
May 25, 2022

Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and

Recruiting
  • Lymphomatoid Granulomatosis
  • +3 more
  • Interferon
  • Rituxan and EPOCH
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Hodgkin Disease Trial in Houston (ABVE-PC, DECA)

Active, not recruiting
  • Hodgkin Disease
  • Houston, Texas
    Texas Children's Hospital
Jan 19, 2022

B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

Not yet recruiting
  • B-cell Non-Hodgkins Lymphoma (B-NHL)
  • (no location specified)
Jan 5, 2023

Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma Trial in Japan (tafasitamab, lenalidomide, parsaclisib)

Recruiting
  • Non Hodgkins Lymphoma
  • Diffuse Large B-cell Lymphoma
  • Aichi, Japan
  • +4 more
Jan 24, 2022

Circulating Cell DNA in Pediatric Mature B Cell Non-Hodgkins

Not yet recruiting
  • Non-hodgkin Lymphoma
  • modified BFM-95 protocol
  • (no location specified)
Jul 9, 2021

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-cell Non Hodgkin Lymphoma
    • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
    • Aurora, Colorado
      Children's Hospital Colorado
    Nov 9, 2022

    Lymphoma, Non-Hodgkin's, Adult Trial in Rosario, Caba (Evaluation of first line treatment in patients with stage I and II LBCL)

    Recruiting
    • Lymphoma, Non-Hodgkin's, Adult
    • Evaluation of first line treatment in patients with stage I and II LBCL
    • Paraná, Entre Ríos, Argentina
    • +6 more
    Dec 29, 2022

    Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)

    Completed
    Has Results
    • Non-Hodgkins Lymphoma
    • Fort Myers, Florida
    • +1 more
    Feb 21, 2022

    Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,

    Terminated
    • Non-Hodgkins Lymphoma
    • +6 more
    • Huntsville, Alabama
    • +1 more
    May 5, 2022

    Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))

    Recruiting
    • Leukemia
    • +5 more
    • Bone Marrow Transplant (BMT)
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Feb 14, 2022

    Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (JBH492)

    Recruiting
    • Non-Hodgkins Lymphoma
    • Chronic Lymphocytic Leukemia
    • Phoenix, Arizona
    • +10 more
    Nov 11, 2022

    Non-Hodgkins Lymphoma Trial in Philadelphia, Houston (hLL2 (epratuzumab))

    Terminated
    • Non-Hodgkins Lymphoma
    • hLL2 (epratuzumab)
    • Philadelphia, Pennsylvania
    • +1 more
    Aug 12, 2021

    Hodgkins Lymphoma Trial in Cologne (Rituximab, BEACOPP escalated)

    Completed
    • Hodgkins Lymphoma
    • Cologne, Germany
      1st Dept. of Medicine, Cologne University Hospital
    Nov 11, 2020

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Relapsed/Refractory Peripheral T-cell Lymphoma, Relapsed/Refractory Classical Hodgkins Lymphoma Trial in Worldwide (AZD4573)

    Recruiting
    • Relapsed/Refractory Peripheral T-cell Lymphoma
    • Relapsed/Refractory Classical Hodgkins Lymphoma
    • Duarte, California
    • +33 more
    Jan 5, 2023

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in China (CD19-targeted Chimeric Antigen

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
    • Beijing, Beijing, China
    • +9 more
    Jan 17, 2021

    Hodgkin Disease Trial in Saint Louis, Winston-Salem, Columbus (Lenalidomide)

    Completed
    • Hodgkin Disease
    • Saint Louis, Missouri
    • +2 more
    Mar 9, 2021

    Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

    Recruiting
    • Non-Hodgkins Lymphoma
    • Charlotte, North Carolina
    • +21 more
    Jan 18, 2023

    Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

    Terminated
    Has Results
    • Lymphoma, B-Cell
    • +3 more
    • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2022